ArticleThe European respiratory journal2018

An inhaled "bifunctional" dual PDE3/4 inhibitor provides additional short-term improvements in lung function compared to existing classes of bronchodilator: implications for future treatment of COPD.

Mario Cazzola et al.PubMed ↗Publisher ↗

No numbers read from the abstract.